Terms: = Lymphoma AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
42 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract] [Full Text] [Related]
4. dnmt3a low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells.
Li W; Liu S; Wang C; Cui L; Zhao X; Liu W; Zhang R; Li Z
BMC Cancer; 2023 Mar; 23(1):255. PubMed ID: 36934225
[TBL] [Abstract] [Full Text] [Related]
5. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
[TBL] [Abstract] [Full Text] [Related]
6. Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas.
de Pádua Covas Lage LA; Culler HF; Barreto GC; Reichert CO; Levy D; de Oliveira Costa R; Rocha V; Pereira J
Clin Epigenetics; 2022 Dec; 14(1):180. PubMed ID: 36536430
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
Testa S; Kumar J; Goodell AJ; Zehnder JL; Alexander KM; Sidana S; Arai S; Witteles RM; Liedtke M
Semin Oncol; 2022 Dec; 49(6):465-475. PubMed ID: 36503855
[TBL] [Abstract] [Full Text] [Related]
8. Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia.
Han H; Yao Y; Wang H; Zhou M; Zhang Z; Xu X; Qi J; Liu Y; Wu D; Han Y
Cancer; 2023 Jan; 129(2):245-254. PubMed ID: 36370049
[TBL] [Abstract] [Full Text] [Related]
9. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
[TBL] [Abstract] [Full Text] [Related]
10. The First Case of Adult Granular Acute Lymphoblastic Leukemia with
Roh J; Cho Y; Han B; Lee YK
Ann Clin Lab Sci; 2022 Sep; 52(5):846-849. PubMed ID: 36261189
[TBL] [Abstract] [Full Text] [Related]
11. Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
Yoon JH; Kim HS; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Lee JW; Kim M; Kim Y; Lee S
Eur J Haematol; 2023 Feb; 110(2):137-148. PubMed ID: 36217591
[TBL] [Abstract] [Full Text] [Related]
12. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract] [Full Text] [Related]
13. The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.
Xu J; Hao Z; Chen X; Hong M; Muyey DM; Chen X; Wang H
Leuk Lymphoma; 2022 Oct; 63(10):2321-2329. PubMed ID: 35652795
[TBL] [Abstract] [Full Text] [Related]
14. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract] [Full Text] [Related]
15. Excellent prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
[TBL] [Abstract] [Full Text] [Related]
16. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract] [Full Text] [Related]
17. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier F; Safar V; Beldi-Ferchiou A; Cottereau AS; Bachy E; Cartron G; Fataccioli V; Pelletier L; Robe C; Letourneau A; Missiaglia E; Fourati S; Moles-Moreau MP; Delmer A; Bouabdallah R; Voillat L; Becker S; Bossard C; Parrens M; Casasnovas O; Cacheux V; Régny C; Camus V; Delfau-Larue MH; Meignan M; de Leval L; Gaulard P; Haioun C
Blood Adv; 2021 Jan; 5(2):539-548. PubMed ID: 33496747
[TBL] [Abstract] [Full Text] [Related]
18. Identification of two novel mutations in human acute myeloid leukemia cases.
O'Brien G; Zyla J; Manola KN; Pagoni MN; Polanska J; Badie C
Leuk Lymphoma; 2021 Feb; 62(2):454-461. PubMed ID: 33161783
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract] [Full Text] [Related]
20. [Current standard in diagnostic and therapy of peripheral T-cell lymphoma].
Hopfinger G; Staber P
Dtsch Med Wochenschr; 2019 Oct; 144(20):1400-1404. PubMed ID: 31594013
[TBL] [Abstract] [Full Text] [Related]
[Next]
